Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial
| dc.contributor.author | Cooper, David A. | |
| dc.contributor.author | Cordery, Damien V. | |
| dc.contributor.author | Zajdenverg, Roberto | |
| dc.contributor.author | Ruxrungtham, Kiat | |
| dc.contributor.author | Arastéh, Keikawus | |
| dc.contributor.author | Bergmann, Frank | |
| dc.contributor.author | Andrade Neto, José L. de | |
| dc.contributor.author | Scherer, Joseph | |
| dc.contributor.author | Chaves, Ricardo L. | |
| dc.contributor.author | Robinson, Patrick | |
| dc.date.accessioned | 2020-09-09T15:51:28Z | |
| dc.date.accessioned | 2023-05-10T17:57:26Z | |
| dc.date.available | 2020-09-09T15:51:28Z | |
| dc.date.available | 2023-05-10T17:57:26Z | |
| dc.date.created | 2016-01-05 | |
| dc.identifier | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144917 | spa |
| dc.identifier.issn | 1932-6203 (Electrónico) | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12032/96877 | |
| dc.format | spa | |
| dc.format.mimetype | application/pdf | spa |
| dc.language | Inglés | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.source | PLoS ONE; Vol. 11 Núm. 1 (2016) | spa |
| dc.title | Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial | spa |
| dc.type | info:eu-repo/semantics/article |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
| journal.pone.0144917.PDF | 748.3Kb | application/pdf | View/ |
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/